Torsten Pietsch

Torsten Pietsch

Auto-generated profile, based on publicly available information

Torsten Pietsch

Institute of Neuropathology, DGNN Brain Tumour Reference Centre, University of Bonn Medical Centre, Bonn, Germany

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 July 2018 in Clinical Neuroradiology
Verified
Journal Article
Closed access
PDF file
JNJohannes Nowak
Johannes Nowak
SJStephanie T. Jünger
Stephanie T. Jünger
HHHenner Huflage
Henner Huflage
CSCarolin Seidel
Carolin Seidel
AHAnnika Hohm
Annika Hohm
MWMonika Warmuth-Metz
Monika Warmuth-Metz

31 October 2020 in Child's Nervous System
Verified
Journal Article
Open access
PDF file
SMSimone Minasi
Simone Minasi
CBCaterina Baldi
Caterina Baldi
FGFrancesca Gianno
Francesca Gianno
Manila AntonelliManila Antonelli
Manila Antonelli
ABAnna Maria Buccoliero
Anna Maria Buccoliero
FBFrancesca Romana Buttarelli
Francesca Romana Buttarelli
Purpose: The maintenance of telomere length prevents cancer cell senescence and occurs via two mutually exclusive mechanisms: (a) reactivation of telomerase expression and (b) activation of alternative lengthening of telomeres (ALT). ALT is frequently related to alterations on ATRX, a chromatin-remodelling protein. Recent data have identified different molecular subgroups of paediatric high-grade glioma (pHGG) with mutations of H3F3A, TERTp and ATRX; however, differences in telomere length among these molecular subgroups were not thoroughly examined. Methods: We investigated which genetic alterations trigger the ALT mechanism in 52 IDH-wildtype, 1p/19q-wildtype pHGG. Samples were analysed for telomere length using Tel-FISH. ATRX nuclear loss of expression was assessed by IHC, H3F3A and TERTp mutations by DNA sequencing, and TERTp methylation by MS-PCR. Results: Mutant H3.3 was found in 21 cases (40.3%): 19.2% with K27M mutation and 21.1% with G34R mutation. All H3.3G34R-mutated cases showed the ALT phenotype (100%); on the opposite, only 40% of the H3.3K27M-mutated showed ALT activation. ATRX nuclear loss was seen in 16 cases (30.7%), associated sometimes with the G34R mutation, and never with the K27M mutation. ATRX nuclear loss was always related to telomere elongation. TERTp C250T mutations were rare (5.4%) and were not associated with high intensity Tel-FISH signals, as TERTp hyper-methylation detected in 21% of the cases. H3.3/ATRX/TERTp-wildtype pHGG revealed all basal levels of telomere length. Conclusion: Our results show a strong association between H3.3 mutations and ALT, and highlight the different telomeric profiles in histone-defined subgroups: H3.3-G34R mutants always trigger ALT to maintain telomere length, irrespective of ATRX status, whereas only some H3.3-K27M tumours activate ALT. These findings suggest that acquiring the gly34 mutation on H3.3 might suffice to trigger the ALT mechanism.

10 August 2017 in American Journal of Neuroradiology
Verified
Journal Article
Open access
PDF file
VKV.C. Keil
V.C. Keil
MWM. Warmuth-Metz
M. Warmuth-Metz
CRC. Reh
C. Reh
SES.J. Enkirch
S.J. Enkirch
CRC. Reinert
C. Reinert
Peter HauPeter Hau
Peter Hau
BACKGROUND AND PURPOSE: The occurrence of medulloblastomas in adults is rare; nevertheless, these tumors can be subdivided into genetic and histologic entities each having distinct prognoses. This study aimed to identify MR imaging biomarkers to classify these entities and to uncover differences in MR imaging biomarkers identified in pediatric medulloblastomas. MATERIALS AND METHODS: Eligible preoperative MRIs from 28 patients (11 women; 22–53 years of age) of the Multicenter Pilot-study for the Therapy of Medulloblastoma of Adults (NOA-7) cohort were assessed by 3 experienced neuroradiologists. Lesions and perifocal edema were volumetrized and multiparametrically evaluated for classic morphologic characteristics, location, hydrocephalus, and Chang criteria. To identify MR imaging biomarkers, we correlated genetic entities sonic hedgehog (SHH) TP53 wild type, wingless (WNT), and non-WNT/non-SHH medulloblastomas (in adults, Group 4), and histologic entities were correlated with the imaging criteria. These MR imaging biomarkers were compared with corresponding data from a pediatric study. RESULTS: There were 19 SHH TP53 wild type (69%), 4 WNT-activated (14%), and 5 Group 4 (17%) medulloblastomas. Six potential MR imaging biomarkers were identified, 3 of which, hydrocephalus (P = .03), intraventricular macrometastases (P = .02), and hemorrhage (P = .04), when combined, could identify WNT medulloblastoma with 100% sensitivity and 88.3% specificity (95% CI, 39.8%–100.0% and 62.6%–95.3%). WNT-activated nuclear β-catenin accumulating medulloblastomas were smaller than the other entities (95% CI, 5.2–22.3 cm3 versus 35.1–47.6 cm3; P = .03). Hemorrhage was exclusively present in non-WNT/non-SHH medulloblastomas (P = .04; n = 2/5). MR imaging biomarkers were all discordant from those identified in the pediatric cohort. Desmoplastic/nodular medulloblastomas were more rarely in contact with the fourth ventricle (4/15 versus 7/13; P = .04). CONCLUSIONS: MR imaging biomarkers can help distinguish histologic and genetic medulloblastoma entities in adults and appear to be different from those identified in children.

1 December 1997 in Journal of Neuro-Oncology
Verified
Journal Article
Closed access
PDF file
TPTorsten Pietsch
Torsten Pietsch
OWOtmar D. Wiestler
Otmar D. Wiestler

4 March 2019 in Journal of Neuro-Oncology
Verified
Journal Article
Closed access
PDF file
SMSimone Minasi
Simone Minasi
CBCaterina Baldi
Caterina Baldi
TPTorsten Pietsch
Torsten Pietsch
VDVittoria Donofrio
Vittoria Donofrio
BPBianca Pollo
Bianca Pollo
FBFrancesca Romana Buttarelli
Francesca Romana Buttarelli

1 August 1999 in Carcinogenesis
Verified
Journal Article
Open access
PDF file
Roland KapplerRoland Kappler
Roland Kappler
TPTorsten Pietsch
Torsten Pietsch
SWSascha Weggen
Sascha Weggen
OWOtmar D. Wiestler
Otmar D. Wiestler
HSHarry Scherthan
Harry Scherthan
Comparative genomic in situ hybridization analysis of four cell lines derived from SV40 large T antigen-induced primitive neuroectodermal tumors of the rat revealed non-recurrent chromosomal copy number changes and DNA amplifications at chromosomal bands 2q34, 4q43qter and 15q12qter in cell lines TZ102, TZ103 and TZ107, respectively. Semi-quantitative PCR and western blot analysis demonstrated amplification and over-expression of the rat N-ras proto-oncogene in TZ102. Furthermore, all cell lines displayed aneuploid cell populations and variable chromosome numbers as assessed by flow cytometry and cytogenetics. These findings suggest that DNA amplification as well as genomic instability may contribute to the pathogenesis of SV40 large T antigen-induced primitive neuroectodermal tumors of the rat.